Phase I clinical and pharmacological study of suppression of human antimouse antibody response to monoclonal antibody L6 by deoxyspergualin. [electronic resource]
Producer: 19950817Description: 3060-7 p. digitalISSN:- 0008-5472
- Adult
- Aged
- Antibiotics, Antineoplastic -- adverse effects
- Antibodies, Anti-Idiotypic -- biosynthesis
- Antibodies, Monoclonal -- adverse effects
- Antibody Formation -- drug effects
- Complement Activation -- drug effects
- Complement C3 -- metabolism
- Complement C4 -- metabolism
- Dose-Response Relationship, Drug
- Drug Interactions
- Female
- Guanidines -- adverse effects
- Humans
- Isoantigens -- immunology
- Male
- Middle Aged
- Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.